Distributor inventory
Insulin glargine (strength/volume not specified) in prefilled disposable pen
Treatment of diabetes mellitus to improve glycaemic control (as basal insulin) in adults and/or children as prescribed by a doctor.
Insulin glargine is a long-acting basal insulin analogue. After subcutaneous injection it forms microprecipitates that slowly release insulin, providing a relatively steady glucose-lowering effect over ~24 hours.
For subcutaneous use only via the disposable pen as instructed by a healthcare professional. Inject once daily at the same time each day (or as prescribed); rotate injection sites (abdomen, thigh, upper arm). Do not inject into a vein or muscle; do not mix with other insulins unless advised. Check the label, solution appearance, and dose before each use; use a new needle each injection and dispose safely.
Common side effects of BASUGINE DISPOSABLE PEN may include:
Risk of severe hypoglycaemia—carry glucose and monitor blood sugar regularly. Dose adjustments may be needed with changes in diet, exercise, illness, renal/hepatic impairment, or when switching insulin products. Do not share pens/needles to prevent infection transmission. Not for treatment of diabetic ketoacidosis. Use caution when driving/operating machinery if hypoglycaemia unawareness. Seek medical help for severe allergy (wheezing, swelling, generalized rash).